Biological actions of cholecystokinin
暂无分享,去创建一个
[1] J. Rehfeld,et al. Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles. , 1980, Advances in biochemical psychopharmacology.
[2] O. Wolkowitz,et al. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist , 1990, Biological Psychiatry.
[3] W. Laughton,et al. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. , 1992, The American journal of physiology.
[4] J. Vanderhaeghen,et al. New peptide in the vertebrate CNS reacting with antigastrin antibodies , 1975, Nature.
[5] D. K. Meyer,et al. Effects of unilateral cortex lesions on gene expression of rat cortical cholecystokinin neurons. , 1991, Brain research. Molecular brain research.
[6] R. Yalow,et al. Brain cholecystokinin in fasted and fed mice. , 1980, Life sciences.
[7] J. Féger,et al. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264 , 1990, Synapse.
[8] R. Yalow,et al. Cholecystokinin octapeptides purified from chinchilla and chicken brains , 1987, Brain Research Bulletin.
[9] Systemic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbils. , 1992, European journal of pharmacology.
[10] John D. Minna,et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.
[11] J. Morley,et al. Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides , 1989, Peptides.
[12] G. P. Smith,et al. Endogenous cholecystokinin does not decrease food intake or gastric emptying in fasted rats. , 1989, The American journal of physiology.
[13] S. Woods,et al. Intraventricular CCK inhibits food intake and gastric emptying in baboons. , 1989, The American journal of physiology.
[14] C. Baile,et al. Changes in brain CCK concentrations with peripheral CCK injections in Zucker rats , 1986, Physiology & Behavior.
[15] T. Davidson,et al. Cholecystokinin, but not bombesin, has interoceptive sensory consequences like 1-h food deprivation , 1993, Physiology & Behavior.
[16] J. Davison,et al. Dibutyryl cyclic GMP, a competitive inhibitor of cholecystokinin/pancreozymin and related peptides in the gallbladder and ileum. , 1981, Canadian journal of physiology and pharmacology.
[17] J. Walsh,et al. Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. , 1992, Gastroenterology.
[18] G. D'mello,et al. Oral Self-Administration and the Relevance of Conditioned Taste Aversions , 1981 .
[19] Kathleen A. Marshall,et al. Lithium chloride, cholecystokinin and meal patterns: Evidence that cholecystokinin suppresses meal size in rats without causing malaise , 1987, Appetite.
[20] C. Owyang,et al. Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. , 1986, The Journal of clinical investigation.
[21] S. Peikin,et al. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat. , 1988, The American journal of physiology.
[22] D. S. Zahm,et al. Specificity in the projection patterns of accumbal core and shell in the rat , 1991, Neuroscience.
[23] M. Forsling,et al. The effects of intravenous administration of cholecystokinin on feeding behaviour and release of pituitary hormones in pigs are not mediated by serotonergic (5-HT3) receptors , 1992, Neuropharmacology.
[24] R. Jensen,et al. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Rehfeld,et al. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing , 1980, Neuroscience.
[26] G. P. Smith,et al. Pharmacological examination of cholecystokinin (CCK-8)-induced contractile activity in the rat isolated pylorus , 1987, Peptides.
[27] K. Pirke,et al. Disturbed cholecystokinin secretion in patients with eating disorders. , 1991, Life sciences.
[28] M. Denavit-Saubié,et al. Different targets involved in the effect of cholecystokinin on respiration. , 1985, European journal of pharmacology.
[29] G. Zetler,et al. Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)☆ , 1981 .
[30] G. Woodruff,et al. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites. , 1992, Neuroreport.
[32] J. Howbert,et al. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons. , 1993, The Journal of pharmacology and experimental therapeutics.
[33] S. Itoh,et al. Effect of caerulein on plasma corticosterone concentration in the rat. , 1980, Life sciences.
[34] B. Bunney,et al. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin , 1987, Brain Research.
[35] J. Quest,et al. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat. , 1983, The Journal of pharmacology and experimental therapeutics.
[36] S. Iversen,et al. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260. , 1991, European journal of pharmacology.
[37] L. Belbeck,et al. The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat. , 1983, Life sciences.
[38] B. Roques,et al. Autoradiographic localization of cholecystokinin binding sites in human cerebellar system using a [125I]CCK8 probe , 1987, Neurochemistry International.
[39] M. Grossman,et al. Inhibition of gastric acid secretion in man by peptide analogues of cholecystokinin. , 1970, The New England journal of medicine.
[40] B. Bianchi,et al. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. , 1991, Molecular pharmacology.
[41] D. Hommer,et al. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat , 1985, Brain Research.
[42] B. Zheng,et al. Brain/gut peptides in fed and fasted rats. , 1987, Endocrinology.
[43] T. Hökfelt,et al. Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. , 1990, The Journal of clinical investigation.
[44] P. Micevych,et al. Role of perinatal estrogens in sexual differentiation of the inhibition of lordosis by exogenous cholecystokinin , 1993, Physiology & Behavior.
[45] S. Iversen,et al. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. , 1989, Science.
[46] W. Creutzfeldt,et al. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. , 1987, Gastroenterology.
[47] T. Ott,et al. CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens , 1991, Brain Research Bulletin.
[48] J M Liesch,et al. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. , 1985, Science.
[49] R. W. Sikes,et al. Effects of CCK-8 in the nucleus accumbens , 1984, Peptides.
[50] X. Pi-Sunyer,et al. C-Terminal octapeptide of cholecystokinin decreases food intake in obese men , 1982, Physiology & Behavior.
[51] W. Creutzfeldt,et al. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. , 1991, The American journal of physiology.
[52] S. Iversen,et al. Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey , 1990, Brain Research.
[54] H. Debas,et al. Inhibition of gastric emptying is a physiological action of cholecystokinin. , 1975, Gastroenterology.
[55] S. Matsukura,et al. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. , 1993, Metabolism: clinical and experimental.
[56] T. Moody,et al. High affinity binding of cholecystokinin to small cell lung cancer cells , 1987, Peptides.
[57] C. Logsdon. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. , 1986, The American journal of physiology.
[58] J. Battey,et al. Differential Gene Expression of CCKA and CCKB Receptors in the Rat Brain , 1993, Molecular and Cellular Neuroscience.
[59] T. Westfall,et al. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro. , 1986, The Journal of pharmacology and experimental therapeutics.
[60] T. Shiraishi. CCK as a central satiety factor: Behavioral and electrophysiological evidence , 1990, Physiology & Behavior.
[61] M. Peschanski,et al. Postnatal development of cholecystokinin (CCK) binding sites in the rat forebrain and midbrain: an autoradiographic study. , 1988, Brain research. Developmental brain research.
[62] S. Butcher,et al. In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion , 1989, Brain Research.
[63] J. Crawley,et al. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens , 1990, Brain Research.
[64] T. Dunwiddie,et al. Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro , 1987, Brain Research.
[65] T. Hökfelt,et al. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection. , 1980, European journal of pharmacology.
[66] F. Vandesande,et al. Cholecystokinin varies in the posterior pituitary and external median eminence of the rat according to factors affecting vasopressin and oxytocin. , 1983, Life sciences.
[67] F. Makovec,et al. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. , 1985, Arzneimittel-Forschung.
[68] B. Balkan,et al. Hepatic-portal and cardiac infusion of CCK-8 and glucagon induce different effects on feeding , 1989, Physiology & Behavior.
[69] Y. Taché,et al. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. , 1988, The American journal of physiology.
[70] R. Jorde,et al. Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation. , 1984, International journal of obesity.
[71] A. Deutch,et al. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell , 1992, Neuroscience.
[72] G. Bray,et al. Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion. , 1992, The American journal of physiology.
[73] C. Defilippi,et al. Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat. , 1981, Gastroenterology.
[74] J. Davison,et al. The effect of vagotomy on the increase in food intake induced by the cholecystokinin antagonist, proglumide , 1985, Regulatory Peptides.
[75] P. Wood,et al. Effect of cholecystokinin on acetylcholine turnover and dopamine release in the rat striatum and cortex. , 1989, European journal of pharmacology.
[76] R. Jensen,et al. Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[77] G. Mogenson,et al. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin , 1991, Brain Research.
[78] L. Bednarz,et al. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats , 1992, Brain Research.
[79] A. Phillips,et al. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine. , 1987, European journal of pharmacology.
[80] C. Blaha,et al. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens , 1986, Brain Research.
[81] L. Bednarz,et al. A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey , 1992, Pharmacology Biochemistry and Behavior.
[82] J. Crawley. Cholecystokinin-dopamine intearctions , 1991 .
[83] S. Cooper,et al. Fluoxetine reduces food intake by a cholecystokinin-independent mechanism , 1990, Pharmacology Biochemistry and Behavior.
[84] R. Chang,et al. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. , 1986, Molecular pharmacology.
[85] R. Jensen,et al. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[86] J. Féger,et al. CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens , 1989, Pharmacology Biochemistry and Behavior.
[87] T. Chase,et al. A comparison of peripheral and central effects of CCK8 on water-reinforced operant responding. , 1985, European journal of pharmacology.
[88] J. Crawley. Comparative Distribution of Cholecystokinin and Other Neuropeptides , 1985, Annals of the New York Academy of Sciences.
[89] S. Iversen,et al. CCK-8 modulation of mesolimbic dopamine: Antagonism of amphetamine-stimulated behaviors , 1983, Peptides.
[90] O. Prospero-Garcia,et al. Cerebroventricular infusion of cholecystokinin (CCK-8) restores REM sleep in parachlorophenylalanine (PCPA)-pretreated cats , 1987, Neuroscience Letters.
[91] F. J. White,et al. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons , 1984, Brain Research.
[92] T. Hökfelt,et al. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[93] R. Reidelberger,et al. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats , 1991, Peptides.
[94] J. Rehfeld,et al. Radioimmunoassay of cholecystokinin in human plasma. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[95] R. Hill,et al. Antagonism of central and peripheral anorectic effects of caerulein by L-364,718. , 1989, European journal of pharmacology.
[96] A. Sandvik,et al. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion. , 1991, The American journal of physiology.
[97] R. Reidelberger,et al. Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs. , 1989, The American journal of physiology.
[98] V. Go,et al. Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus , 1987, Brain Research.
[99] R. Chang,et al. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[100] C. Baile,et al. CNS injection of CCK in rats: effects on real and sham feeding and gastric emptying. , 1990, The American journal of physiology.
[101] D. Dahl. Systemically administered cholecystokinin affects an evoked potential in the hippocampal dentate gyrus , 1987, Neuropeptides.
[102] S. Konturek,et al. Cholecystokinin receptors and vagal nerves in control of food intake in rats. , 1990, The American journal of physiology.
[103] J. Born,et al. Effects of cholecystokinin and calcitonin on evoked brain potentials and satiety in man , 1989, Physiology & Behavior.
[104] Menek Goldstein,et al. Chapter 4 Coexistence of neuronal messengers — an overview , 1986 .
[105] J. Walsh,et al. Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma , 1984, Regulatory Peptides.
[106] G. P. Smith,et al. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats. , 1992, The American journal of physiology.
[107] Pendleton Rg,et al. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat , 1988 .
[108] J. Vanderhaeghen,et al. Distribution of immunoreactive cholecystokinin in the human hippocampus , 1987, Peptides.
[109] R J Gould,et al. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.
[110] C. Altar,et al. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release , 1988, Brain Research.
[111] I. Goldfine,et al. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. , 1985, The Journal of clinical investigation.
[112] Y. Kubota,et al. Ontogeny of cholecystokinin‐8‐containing neuron system of the rat: An immunohistochemical analysis. I. Forebrain and upper brainstem , 1983, The Journal of comparative neurology.
[113] S. Efendić,et al. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. , 1982, Endocrinology.
[114] D. Rees,et al. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. , 1993, Journal of medicinal chemistry.
[115] B. Roques,et al. Neuroleptic-like properties of cholecystokinin analogs: Distinctive mechanisms underlying similar behavioral profiles depending on the route of administration , 1988, Peptides.
[116] P. McHugh,et al. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. , 1993, The American journal of physiology.
[117] D. K. Meyer,et al. Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum. , 1984, European journal of pharmacology.
[118] G. Mogenson,et al. Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens , 1991, Brain Research.
[119] J. Rehfeld,et al. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. , 1978, The Journal of biological chemistry.
[120] J. Morley,et al. Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala , 1992, Brain Research.
[121] R. Ritter,et al. Dorsomedial hindbrain participation in cholecystokinin-induced satiety. , 1986, The American journal of physiology.
[122] J. Davison,et al. The cholecystokinin antagonist, proglumide, increases food intake in the rat , 1984, Regulatory Peptides.
[123] R. Jensen,et al. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. , 1983, The Journal of biological chemistry.
[124] W. Chey,et al. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. , 1970, Gastroenterology.
[125] R. Unger,et al. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. , 1977, The Journal of clinical investigation.
[126] Trevor W. Robbins,et al. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement , 1993, Behavioural Brain Research.
[127] P. Miller,et al. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. , 1986, The American journal of physiology.
[128] M. Grossman,et al. Effect of secretin and cholecystokinin on pentagastrin-stimulated gastric secretion in man. , 1970, Gastroenterology.
[129] D. K. Meyer,et al. Dopamine modulates cholecystokinin release in neostriatum , 1983, Nature.
[130] C. Jacquot,et al. Variability of changes in obese rat brain monoamines in response to cholecystokinin. , 1986, General pharmacology.
[131] A. Steggles,et al. Characterization of Cholecystokinin Binding Sites in Rat Cerebral Cortex Using a 125I‐CCK‐8 Probe Resistant to Degradation , 1983, Journal of neurochemistry.
[132] P. Maton,et al. Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay , 1982, Regulatory Peptides.
[133] B. A. Baldwin,et al. Operant feeding and drinking in pigs following intracerebroventricular injection of synthetic cholecystokinin octapeptide , 1981, Physiology & Behavior.
[134] H. Raybould,et al. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats. , 1992, The American journal of physiology.
[135] L. Chiodo,et al. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons , 1991, Synapse.
[136] B. Penke,et al. Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration , 1984, Neuropharmacology.
[137] H. Raper,et al. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine , 1943, The Journal of physiology.
[138] S. Iversen,et al. Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys , 1993, Neuropeptides.
[139] J. Féger,et al. The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat. , 1989, European journal of pharmacology.
[140] G. Koob,et al. Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward , 1984, Neuroscience Letters.
[141] J. Polak,et al. Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK. , 1978, Gut.
[142] J. Morley,et al. The effect of vagotomy on the satiety effects of neuropeptides and naloxone. , 1982, Life sciences.
[143] M. Brownstein,et al. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay , 1981, Brain Research.
[144] S. Dunnett,et al. Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: Evidence for selective growth regulation , 1984, Neuroscience.
[145] J. Rehfeld,et al. Ontogeny of procholecystokinin maturation in rat duodenum, jejunum, and ileum. , 1992, Gastroenterology.
[146] S. Wank,et al. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. , 1992, Biochemical and biophysical research communications.
[147] R. Corwin,et al. Anorectic specificity as measured in a choice paradigm in rhesus monkeys , 1993, Pharmacology Biochemistry and Behavior.
[148] G. P. Smith,et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.
[149] R. Nesse,et al. Cholecystokinin-4 and panic. , 1990, Archives of general psychiatry.
[150] M. Beinfeld,et al. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor , 1986, Brain Research.
[151] P. Riederer,et al. Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[152] F. Goodwin,et al. Demonstration of a putative receptor site for cholecystokinin in rat brain , 1980, Neuropeptides.
[153] P. Corringer,et al. [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors. , 1989, European journal of pharmacology.
[154] H. Raybould,et al. Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[155] R. Farmer,et al. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease , 1992 .
[156] R. Liddle,et al. Regulation of gastric emptying in humans by cholecystokinin. , 1986, The Journal of clinical investigation.
[157] S. Paul,et al. Postnatal ontogeny of cholecystokinin receptors in rat brain , 1981, Brain Research.
[158] H. Bauer,et al. Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man , 1979, Physiology & Behavior.
[159] K. Inouye,et al. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat , 1989, Peptides.
[160] T. Brewerton,et al. CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. , 1993, The American journal of psychiatry.
[161] S. Berlangieri,et al. Central and peripheral effects of CCK receptor antagonists on satiety in dogs. , 1993, The American journal of physiology.
[162] J. Glowinski,et al. Autoradiography of CCK receptors in the rat brain using [3H]Boc[Nle28 31]CCK27–33 and [125I]bolton-hunter CCK8. Functional significance of subregional distributions , 1987, Neurochemistry International.
[163] P. McHugh,et al. Gastric branch vagotomy blocks nutrient and cholecystokinin-induced suppression of gastric emptying. , 1993, The American journal of physiology.
[164] M. Cullen,et al. Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor , 1989, Pharmacology Biochemistry and Behavior.
[165] K. Hermansen. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. , 1984, Endocrinology.
[166] P. Kerstens,et al. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. , 1985, Life sciences.
[167] P. McHugh,et al. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. , 1992, The American journal of physiology.
[168] B. Roques,et al. Cyclic cholecystokinin analogues with high selectivity for central receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[169] R. Reidelberger,et al. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. , 1989, The American journal of physiology.
[170] C. Turkelson,et al. A cholecystokinin-metabolizing enzyme in rat intestine , 1990, Peptides.
[171] C. Beglinger,et al. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. , 1990, The Journal of clinical investigation.
[172] J. Morley,et al. Feeding systems in Chinese hamsters. , 1984, The American journal of physiology.
[173] L. Rovati,et al. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. , 1989, Gut.
[174] S. Paul,et al. CCK receptors and human neurological disease. , 1982, Life sciences.
[175] T. Hökfelt,et al. Evidence for coexistence of dopamine and CCK in meso-limbic neurones , 1980, Nature.
[176] C. de Montigny,et al. Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat. , 1988, European Journal of Pharmacology.
[177] D. Farningham,et al. Satiety signals in sheep: Involvement of CCK, propionate, and vagal CCK binding sites , 1993, Physiology & Behavior.
[178] M. Anika. Effects of cholecystokinin and caerulein on gastric emptying. , 1982, European journal of pharmacology.
[179] R. Quirion,et al. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites , 1990, Neuropeptides.
[180] C. Baile,et al. Meal-stimulated increased concentrations of CCK in the hypothalamus of Zucker obese and lean rats , 1985, Physiology & Behavior.
[181] Y. Shinomura,et al. Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat , 1991, Regulatory Peptides.
[182] T. Hökfelt,et al. Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[183] J. Vanderhaeghen,et al. Cholecystokinin receptors of A type in the human dorsal medulla oblongata and meningiomas, and of B type in small cell lung carcinomas , 1990, Neuroscience Letters.
[184] L. Way. Effect of cholecystokinin and caerulein on gastric secretion in cats. , 1971, Gastroenterology.
[185] D. Hommer,et al. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype , 1986, Journal of Neuroscience.
[186] W. Chey,et al. Actions and interactions of gut hormones and histamine on gastric secretion of acid in the rat. , 1973, The American journal of physiology.
[187] J. Barrett,et al. Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys , 1991, Neuropeptides.
[188] G. Katsuura,et al. Protective effect of CCK-8 and ceruletide on glutamate-induced neuronal cell death in rat neuron cultures: Possible involvement of CCK-B receptors , 1991, Neuroscience Letters.
[189] F. Mora,et al. Peptides and self-stimulation of the medial prefrontal cortex in the rat: Effects of intracerebral microinjections of substance P and cholecystokinin , 1988, Peptides.
[190] B. Penke,et al. Degradation of cholecystokinin octapeptide by the neutral endopeptidase EC 3.4.24.11 and design of proteolysis-resistant analogues of the peptide , 1987, Neurochemistry International.
[191] B. Roques,et al. Enzyme-resistant CCK analogs with high affinities for central receptors , 1988, Peptides.
[192] J. Vanderhaeghen,et al. Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventricles , 1987, Neurochemistry International.
[193] P. Södersten,et al. Involvement of Cholecystokinin in Food Intake: I. Concentrations of Cholecystokinin‐Like Immunoreactivity in the Cerebrospinal Fluid of Male Rats , 1990, Journal of neuroendocrinology.
[194] R. Innis,et al. Cholecystokinin receptor binding in brain and pancreas: Regulation of pancreatic bindign by cyclic and acyclic guanine nucleotides , 1980 .
[195] A. Tsuji,et al. Effect of low-frequency electric stimulation on in vivo release of cholecystokinin-like immunoreactivity in medial thalamus of conscious rat , 1990, Neuroscience Letters.
[196] G. P. Smith,et al. Effect of cholecystokinin, gastrin, secretin and GIP on sham feeding in the rat , 1979, Physiology & Behavior.
[197] J. Crawley. Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors , 1983, Peptides.
[198] H. Worning,et al. Cholecystokinetic and pancreozymic effect of O-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin. , 1986, Gastroenterology.
[199] P. McHugh,et al. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches , 1987, Brain Research.
[200] T. Moody,et al. Growth factor and peptide receptors in small cell lung cancer. , 1993, Life sciences.
[201] J. Howbert,et al. Inhibition of A9 and A10 dopamine cells by the cholecystokinin‐B antagonist LY262691: Mediation through feedback pathways from forebrain sites , 1993, Synapse.
[202] R. Hill,et al. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin , 1988, British journal of pharmacology.
[203] S. Itoh,et al. Specificity of nucleus accumbens to activities related to cholecystokinins in rats , 1985, Peptides.
[204] T. Chase,et al. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy. , 1982, European journal of pharmacology.
[205] J. Morley,et al. Evidence for a physiological role for CCK in the regulation of food intake in mice. , 1989, The American journal of physiology.
[206] J. Crawley. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine‐induced hypolocomotion , 1989, Synapse.
[207] N. Bunnett,et al. Intestinal acid inhibits gastric acid secretion by neural and hormonal mechanisms in rats. , 1992, The American journal of physiology.
[208] S. Wank,et al. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[209] J. Rehfeld,et al. Identification of cholecystokinin/gastrin peptides in frog and turtle. Evidence that cholecystokinin is phylogenetically older than gastrin. , 1992, European journal of biochemistry.
[210] Paul R. McHugh,et al. Two brain cholecystokinin receptors: implications for behavioral actions , 1986, Brain Research.
[211] S. Schiffmann,et al. Cholecystokinin mRNA detection in rat spinal cord motoneurons but not in dorsal root ganglia neurons , 1991, Neuroscience Letters.
[212] J. Rehfeld,et al. N-Terminal fragments of intestinal cholecystokinin: evidence for release of CCK-8 by cleavage on the carboxyl side of Arg74 of proCCK , 1993, Regulatory Peptides.
[213] A. Ivy,et al. A HORMONE MECHANISM FOR GALL-BLADDER CONTRACTION AND EVACUATION , 1928 .
[214] R. Corwin,et al. Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation. , 1990, The Journal of pharmacology and experimental therapeutics.
[215] C. Schneider,et al. Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man , 1982, Peptides.
[216] E G Jones,et al. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[217] B. Bunney,et al. Does the cholecystokinin antagonist proglumide possess antipsychotic activity? , 1986, Psychiatry Research.
[218] P. McHugh,et al. Integration of vagal afferent responses to gastric loads and cholecystokinin in rats. , 1991, The American journal of physiology.
[219] V. Mutt,et al. Structure of Porcine Cholecystokinin‐Pancreozymin , 1968 .
[220] S. Itoh,et al. Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats. , 1984, Life sciences.
[221] R. Jensen,et al. Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. , 1982, The Journal of biological chemistry.
[222] W. Millington,et al. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment , 1992, Neuropeptides.
[223] J. Bradwejn,et al. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. , 1994, The American journal of psychiatry.
[224] J. Valenzuela,et al. Cholecystokinin-octapeptidelike immunoreactivity in human plasma. , 1982, Gastroenterology.
[225] E. Bouras,et al. Evidence for indirect dietary regulation of cholecystokinin release in rats. , 1993, The American journal of physiology.
[226] J. Crawley,et al. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin. , 1988, Life sciences.
[227] M. R. Hokin. Studies on chemical mechanisms of the action of neurotransmitters and hormones. I. Relationship between hormone stimulated 32P incorporation into phosphatidic acid and into phosphatidylinositol in pigeon pancreas slices. , 1968, Archives of biochemistry and biophysics.
[228] Jacqueline N. Crawley,et al. Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens , 1988, Brain Research.
[229] J. Howbert,et al. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. , 1991, European journal of pharmacology.
[230] G. Böhme,et al. ‘Anxiolytic’ effect of CCK-antagonists on plus-maze behavior in mice , 1991, Brain Research.
[231] W. Oldendorf,et al. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation , 1982, Brain Research.
[232] P. Verbanck,et al. Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders. , 1984, Life sciences.
[233] B. Penke,et al. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice , 1985, Neuropeptides.
[234] G. P. Smith,et al. Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.
[235] N. Maidment,et al. Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassay , 1991, Neuroscience.
[236] T. Hökfelt,et al. Detection of cholecystokinin in spermatogenic cells. , 1988, Acta physiologica Scandinavica.
[237] G. P. Smith,et al. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin , 1993, Peptides.
[238] G. Debonnel,et al. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[239] T. Hökfelt,et al. Immunocytochemical demonstration of cholecystokinin-like immunoreactivity in spermatozoa in monkey testis and epididymis. , 1989, Acta physiologica Scandinavica.
[240] T. Yaksh,et al. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats — pharmacological characterization of this action , 1986, Regulatory Peptides.
[241] J. Morley,et al. Do peptide-induced changes in feeding occur because of changes in motivation to eat? , 1990, Peptides.
[242] G. P. Smith,et al. Proglumide fails to increase food intake after an ingested preload , 1986, Peptides.
[243] J. Bradwejn,et al. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. , 1991, Archives of general psychiatry.
[244] W. Millington,et al. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary. , 1992, The Journal of pharmacology and experimental therapeutics.
[245] A. Steggles,et al. Changes in Cholecystokinin receptor binding in rat brain after food deprivation , 1983, Brain Research.
[246] The single-item meal as a measure of binge-eating behavior in patients with bulimia nervosa , 1992, Physiology & Behavior.
[247] C. Dourish,et al. Classification and function of CCK receptors , 1987 .
[248] J. Gibbs,et al. Vagotomy fails to block the satiating effect of food in the stomach , 1980, Physiology & Behavior.
[249] F. Pi‐Sunyer,et al. Cholecystokinin (CCK-8) affects gastric pressure and ratings of hunger and fullness in women. , 1992, The American journal of physiology.
[250] J. Elashoff,et al. Gastrin receptors on isolated canine parietal cells. , 1984, The Journal of clinical investigation.
[251] R. Pullen,et al. Penetration of diazepam and the non‐peptide CCK antagonist, L‐364, 718, into rat brain , 1987, The Journal of pharmacy and pharmacology.
[252] J. Palacios,et al. Beta adrenergic receptor localization in rat brain by light microscopic autoradiography , 1982, Neurochemistry International.
[253] G. P. Smith,et al. Increased food intake after type A but not type B cholecystokinin receptor blockade , 1991, Physiology & Behavior.
[254] J. Ballenger,et al. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. , 1992, The American journal of psychiatry.
[255] B. Gorzalka,et al. Cholecystokinin-octapeptide produces inhibition of lordosis in the female rat , 1984, Pharmacology Biochemistry and Behavior.
[256] J. Morley,et al. Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. , 1987, Science.
[257] R. Gingerich,et al. Cholecystokinin concentration in specific brain areas of rats fed during the light or dark phase of the circadian cycle , 1989, Physiology & Behavior.
[258] R. Mansbach,et al. Cholecystokinin (CCK-8) elicits prandial sleep in rats , 1983, Physiology & Behavior.
[259] G. P. Smith,et al. Cholecystokinin-induced satiety depends on activation of 5-HT1C receptors. , 1993, The American journal of physiology.
[260] G. P. Smith,et al. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups , 1991, Pharmacology Biochemistry and Behavior.
[261] L. F. Kolakowski,et al. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. , 1993, The Journal of biological chemistry.
[262] M. Rogawski. Cholecystokinin octapeptide: Effects on the excitability of cultured spinal neurons , 1982, Peptides.
[263] S. Konturek,et al. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion , 1992, Regulatory Peptides.
[264] R. Murphy,et al. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists , 1992, Peptides.
[265] G. Green,et al. Plasma cholecystokinin and pancreatic growth during adaptation to dietary protein. , 1986, The American journal of physiology.
[266] I. Goldfine,et al. Characterization of Receptors for Cholecystokinin and Related Peptides in Mouse Cerebral Cortex , 1981, Journal of neurochemistry.
[267] R. Young,et al. Cholecystokinin elicits Satiety in Rats with Open Gastric Fistulas , 1973, Nature.
[268] E. Stellar,et al. Brain cholecystokinin as a satiety peptide , 1986, Physiology & Behavior.
[269] Y. Agid,et al. CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients , 1982, Brain Research.
[270] I. Goldfine,et al. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. , 1987, The Journal of clinical endocrinology and metabolism.
[271] S. Peikin,et al. Trypsin inhibitor effects on food intake and weight gain in zucker rats , 1983, Physiology & Behavior.
[272] C. Jacquot,et al. Effects of a new cholecystokinin analogue (JMV 236) on food intake and brain monoamines in the rat , 1990, Neuropeptides.
[273] M. Hamon,et al. Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra , 1992, Journal of neurochemistry.
[274] G. Shulman,et al. Physiological Role of Cholecystokinin in Meal-Induced Insulin Secretion in Conscious Rats: Studies With L 364718, A Specific Inhibitor of CCK-Receptor Binding , 1987, Diabetes.
[275] S. Cooper,et al. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding , 1990, Physiology & Behavior.
[276] K. Terashi,et al. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. , 1979, The Journal of clinical investigation.
[277] J. Williams,et al. Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. , 1980, The Journal of biological chemistry.
[278] B. Komisaruk,et al. Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin. , 1984, Science.
[279] R. Ritter,et al. Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety , 1988, Peptides.
[280] J. Harro,et al. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. , 1991, European journal of pharmacology.
[281] T. Hökfelt,et al. Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: Immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β-hydroxylase , 1980, Neuroscience.
[282] T. Hökfelt,et al. Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues , 1991, Neuropeptides.
[283] S. Itoh,et al. Effect of cholecystokinin octapeptide on body temperature in the rat. , 1981, The Japanese journal of physiology.
[284] J. Kiss,et al. Cholecystokinin in the Medial Parvocellular Subdivision of the Paraventricular Nucleus: Co‐existence with Corticotropin‐releasing Hormone , 1985, Annals of the New York Academy of Sciences.
[285] D. Reis,et al. Somatostatin and CCK-8 modulate release of striatal amino acids: Role of dopamine receptors , 1986, Peptides.
[286] R. Liddle,et al. Influence of food deprivation on intestinal cholecystokinin and somatostatin. , 1991, Gastroenterology.
[287] B. Roques,et al. Evidence for an endogenous cholecystokininergic balance in social memory. , 1992, Neuroreport.
[288] R. Spealman. Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine , 1992, Pharmacology Biochemistry and Behavior.
[289] J. D. De Mey,et al. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[290] J. Crawley,et al. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[291] G. Woodruff,et al. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329 , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[292] J. Jansen,et al. Physiological role and localization of cholecystokinin release in dogs. , 1986, The American journal of physiology.
[293] F. Makovec,et al. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats , 1986, Regulatory Peptides.
[294] J. Carter,et al. Dietary regulation of rat intestinal cholecystokinin gene expression. , 1988, The Journal of clinical investigation.
[295] J. Palacios,et al. Does cholecystokinin colocalize with dopamine in the human substantia nigra? , 1989, Brain Research.
[296] K. Shimizu,et al. Effect of CCK Antagonists CR 1409 and CR 1505 on Rat Pancreatic Exocrine Secretion In Vivo , 1989, Pancreas.
[297] G. Sedvall,et al. CCK peptides and mRNA in the human brain , 1993, Progress in Neurobiology.
[298] C. Montigny,et al. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones , 1984, Nature.
[299] F. Pi‐Sunyer,et al. Effect of a soup preload on reduction of food intake by cholecystokinin in humans. , 1991, The American journal of physiology.
[300] J. Morley,et al. Minireview. The ascent of cholecystokinin (CCK) - from gut to brain. , 1982, Life sciences.
[301] S. Reines,et al. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder , 1992, Biological Psychiatry.
[302] R. Ritter,et al. Trypsin inhibitor and maternal reunion increase plasma cholecystokinin in neonatal rats , 1992, Peptides.
[303] S. Caccia,et al. Reciprocal interaction of 5‐hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats , 1993, British journal of pharmacology.
[304] B. Hoffman,et al. Cloned cDNA to cholecystokinin mRNA predicts an identical preprocholecystokinin in pig brain and gut. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[305] L. Chiodo,et al. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons , 1988, Brain Research.
[306] V. Go,et al. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures , 1983, Brain Research.
[307] T. Hökfelt,et al. Transient expression of the cholecystokinin gene in male germ cells and accumulation of the peptide in the acrosomal granule: possible role of cholecystokinin in fertilization. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[308] R. Hill,et al. Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases , 1989, British journal of pharmacology.
[309] P. Södersten,et al. Sexual activity increases plasma concentrations of cholecystokinin octapeptide and offsets hunger in male rats. , 1987, The Journal of endocrinology.
[310] R. Woutersen,et al. Cholecystokinin and gastrointestinal cancer , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[311] D. Niehoff. Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8 , 1989, Peptides.
[312] D. de Wied,et al. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. , 1983, European journal of pharmacology.
[313] F. Pi‐Sunyer,et al. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. , 1992, The American journal of physiology.
[314] C. Pert,et al. Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain. , 1983, European journal of pharmacology.
[315] R. Innis,et al. Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. , 1981, Life sciences.
[316] C. Montigny,et al. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. , 1989 .
[317] M. J. Shaw,et al. Species Differences in the Response to Cholecystokinin , 1985, Annals of the New York Academy of Sciences.
[318] S. Paul,et al. Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors , 1981 .
[319] B. Costall,et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[320] B. Gertz,et al. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. , 1989, The Journal of clinical investigation.
[321] J. Glowinski,et al. Cholecystokinin: Corelease with dopamine from nigrostriatal neurons in the cat , 1989, The European journal of neuroscience.
[322] P. Hamosh,et al. Respiratory and cardiovascular effects of intraventricular cholecystokinin. , 1982, European journal of pharmacology.
[323] V. J. Lotti,et al. Fasting and L-364,718 prevent cholecystokinin-induced elevations of plasma insulin levels. , 1987, European journal of pharmacology.
[324] J. Morley,et al. Intraventricular cholecystokinin-octapeptide produces hypothermia in rats. , 1981, European journal of pharmacology.
[325] A. Akaike,et al. Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity , 1991, Brain Research.
[326] A. Sclafani,et al. Cholecystokinin conditions flavor preferences in rats. , 1991, The American journal of physiology.
[327] J. Williams,et al. Evidence That Cholecystokinin Interacts with Specific Receptors and Regulates Insulin Release in Isolated Rat Islets of Langerhans , 1986, Diabetes.
[328] J. Kelly,et al. Cholecystokinin and gastrin as transmitters in the mammalian central nervous system. , 1981, Advances in biochemical psychopharmacology.
[329] A. Kopin,et al. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists , 1993, Nature.
[330] J. Crawley,et al. Microdialysis as an approach to quantitate the release of neuropeptides , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[331] J. Elashoff,et al. Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in short-term culture. , 1985, The American journal of physiology.
[332] J. Vanderhaeghen,et al. High concentration of cholecystokinin neurons in the newborn human entorhinal cortex , 1987, Neuroscience Letters.
[333] G. P. Smith,et al. Ceruletide acts in the abdomen, not in the brain, to produce satiety , 1984, Peptides.
[334] J. Crawley,et al. Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin , 1985, Peptides.
[335] J. Harro,et al. Age-related differences of cholecystokinin receptor binding in the rat brain , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[336] J. Schwaber,et al. Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius , 1984, Brain Research.
[337] J. Fudge,et al. Scheduled running wheel activity indexes the specificity of pharmacological anorexia. , 1992, Behavioral and neural biology.
[338] M. Palkovits,et al. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[339] F. Kraly. Vagotomy does not alter cholecystokinin's inhibition of sham feeding. , 1984, The American journal of physiology.
[340] C. Niederau,et al. Cholecystokinin does not delay gastric emptying of regular meals in healthy humans. , 1993, Hepato-gastroenterology.
[341] T. Geracioti,et al. Impaired cholecystokinin secretion in bulimia nervosa. , 1988, The New England journal of medicine.
[342] G. Zetler. Cholecystokinin octapeptide, caerulein and caerulein analogues: Effects on thermoregulation in the mouse , 1982, Neuropharmacology.
[343] U. Ungerstedt,et al. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat , 1987, Neurochemistry International.
[344] D. Jaffe,et al. The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice , 1987, Brain Research.
[345] L. Watkins,et al. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.
[346] C. Blaha,et al. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat , 1987, Regulatory Peptides.
[347] J. Han,et al. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord. , 1993, European journal of pharmacology.
[348] T. T. Survill,et al. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. , 1992, Gastroenterology.
[349] L. Watkins,et al. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates , 1985, Brain Research.
[350] P. Eneroth,et al. Stimulation of Maternal Behaviour in Rats with Cholecystokinin Octapeptide , 1989, Journal of neuroendocrinology.
[351] J. Crawley,et al. Potency of CR 1409, a new proglumide analog, on cholecystokinin-mediated behaviors and receptor binding , 1987, Neurochemistry International.
[352] S. Iversen,et al. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. , 1990, European journal of pharmacology.
[353] G. Dockray,et al. Gastric emptying in rats: role of afferent neurons and cholecystokinin. , 1990, The American journal of physiology.
[354] V. Mutt,et al. Cholecystokinin and pancreozymin, one single hormone? , 1966, Acta physiologica Scandinavica.
[355] B. A. Baldwin,et al. Effects of the CCK receptor antagonist MK-329 on food intake in pigs , 1990, Physiology & Behavior.
[356] K. Simansky,et al. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats , 1992, Pharmacology Biochemistry and Behavior.
[357] T. Salt,et al. The effects of C-terminal fragments of cholecystokinin on the firing of single neurones in the caudal trigeminal nucleus of the rat , 1982, Neuropeptides.
[358] S. Iversen,et al. Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors. , 1989, European journal of pharmacology.
[359] M. Demitrack,et al. Regulation of appetite and cholecystokinin secretion in anorexia nervosa. , 1992, The American journal of psychiatry.
[360] M. Galas,et al. Pharmacological characterization of new cholecystokinin analogues. , 1992, European journal of pharmacology.
[361] A. Scallet,et al. Satiety, hunger and regional brain content of cholecystokinin/gastrin and met-enkephalin immunoreactivity in sheep , 1985, Peptides.
[362] G. Eberlein,et al. Cholecystokinin-58 is the major molecular form in man, dog and cat but not in pig, beef and rat intestine , 1988, Peptides.
[363] I. Goldfine,et al. Cholecystokinin receptors in the brain: characterization and distribution. , 1980, Science.
[364] P. Anderson,et al. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. , 1989, Gut.
[365] T. Hökfelt,et al. Immunohistochemical studies on cholecystokinin (CCK)-immunoreactive neurons in the rat using sequence specific antisera and with special reference to the caudate nucleus and primary sensory neurons. , 1988, Journal of chemical neuroanatomy.
[366] J. Crawley,et al. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. , 1991, The Journal of pharmacology and experimental therapeutics.
[367] M. Randić,et al. Cholecystokinin octapeptide excites dorsal horn neurons both in vivo and in vitro , 1981, Brain Research.
[368] D. Gully,et al. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. , 1993, European journal of pharmacology.
[369] J. Beck,et al. Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. , 1969, The Journal of clinical investigation.
[370] J. Crawley,et al. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide. , 1984, The Journal of pharmacology and experimental therapeutics.
[371] J. Harro,et al. Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. , 1990, European journal of pharmacology.
[372] L. Johnson,et al. Effect of Secretin and Cholecystokinin on the Response of the Gastric Fistula Rat to Pentagastrin , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[373] J. Crawley,et al. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin , 1982, Neuropeptides.
[374] F. Marshall,et al. Cholecystokinin Modulates the Release of Dopamine from the Anterior and Posterior Nucleus Accumbens by Two Different Mechanisms , 1991, Journal of neurochemistry.
[375] S. Iversen,et al. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. , 1988, European journal of pharmacology.
[376] Wormsley Kg. Gastric response to secretin and pancreoxymin in man. , 1968 .
[377] J. A. Deutsch,et al. An antiemetic is antidotal to the satiety effects of cholecystokinin , 1985, Nature.
[378] J. Palacios,et al. Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization. , 1990, Brain research. Molecular brain research.
[379] T. Yaksh,et al. Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: A mapping study , 1990, Neuropharmacology.
[380] P. Somogyi,et al. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[381] Steven A. Goldman,et al. Vagal mediation of the cholecystokinin satiety effect in rats , 1982, Physiology & Behavior.
[382] J. Mercer,et al. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve , 1992, Neuroscience Letters.
[383] S. Cooper,et al. Reversal of the anorectic effect of (+)‐fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK‐329 , 1990, British journal of pharmacology.
[384] G. P. Smith,et al. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats , 1992, Pharmacology Biochemistry and Behavior.
[385] F. Goodwin,et al. Cholecystokinin reduces exploratory behavior in mice , 1981, Physiology & Behavior.
[386] J. Schwartz,et al. Assessment of the role of “enkephalinase” in cholecystokinin inactivation , 1985, Neuroscience.
[387] R. Ritter,et al. Low-dose near-celiac arterial cholecystokinin suppresses food intake in rats. , 1992, The American journal of physiology.
[388] L. Johnson,et al. Effect of cholecystokinin and caerulein on gastrin- and histamine-evoked gastric secretion. , 1969, Gastroenterology.
[389] T. Hökfelt,et al. Distribution of Cholecystokinin‐like Immunoreactivity in the Nervous System , 1985 .
[390] R. Nustede,et al. Feedback Regulation of Exocrine Pancreatic Secretion in Dogs , 1993, Pancreas.
[391] R. Shamburek,et al. Control of acid secretion. , 1990, Gastroenterology clinics of North America.
[392] F. Vaccarino,et al. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. , 1989, Behavioral neuroscience.
[393] G. P. Smith,et al. Endogenous cholecystokinin reduces feeding in young rats. , 1990, Science.
[394] G. P. Smith,et al. The 5-HT1A agonist 8-OH-DPAT attenuates the satiating action of cholecystokinin , 1992, Pharmacology Biochemistry and Behavior.
[395] M. Verhage,et al. Characterization of the Release of Cholecystokinin‐8 from Isolated Nerve Terminals and Comparison with Exocytosis of Classical Transmitters , 1991, Journal of neurochemistry.
[396] D. Hommer,et al. Chapter 25 Functional studies of cholecystokinin-dopamine coexistence: electrophysiology and behavior , 1986 .
[397] G. Woodruff,et al. The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist , 1991, British journal of pharmacology.
[398] J. Liebman,et al. Antagonism of morphine analgesia by CCK-8-S does not extend to all assays nor all opiate analgesics , 1988, Peptides.
[399] C. Beglinger,et al. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. , 1985, The Journal of clinical investigation.
[400] T. Moran,et al. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve , 1993, Brain Research.
[401] Grossman Mi,et al. Gastrin-related peptides as stimulants of pancreatic and gastric secretion. , 1969 .
[402] I. Goldfine,et al. Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol , 1984 .
[403] R. Mishra,et al. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats , 1987, Peptides.
[404] R. Deschenes,et al. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[405] J. Rehfeld,et al. Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons , 1981, Neuroscience.
[406] J. Palacios,et al. The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined byin situ hybridization , 1989, Neuroscience.
[407] S. Paul,et al. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[408] L. Rovati,et al. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. , 1990, Digestion.
[409] B. Bianchi,et al. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens , 1989, Neuropeptides.
[410] G. P. Smith,et al. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. , 1975, Journal of comparative and physiological psychology.
[411] J. Glowinski,et al. Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat , 1981, Neuropeptides.
[412] P. Micevych,et al. Injections of cholecystokinin into the ventromedial hypothalamic nucleus inhibit lordosis behavior in the rat , 1988, Physiology & Behavior.
[413] A. Vaccarino,et al. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: Differential effects on brain stimulation reward , 1989, Neuroscience Letters.
[414] G. Zetler. Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol , 1981, Neuropharmacology.
[415] G. Woodruff,et al. Pharmacology of a cholecystokinin receptor on 5‐hydroxytryptamine neurones in the dorsal raphe of the rat brain , 1991, British journal of pharmacology.
[416] J. A. Deutsch,et al. Cholecystokinin produces bait shyness in rats , 1977, Nature.
[417] G. Woodruff,et al. Functional role of brain CCK receptors , 1991, Neuropeptides.
[418] K. Mueller,et al. Specificity of cholecystokinin satiety effect: Reduction of food but not water intake , 1977, Pharmacology Biochemistry and Behavior.
[419] M. Bock,et al. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. , 1989, Molecular pharmacology.
[420] R. Ritter,et al. Capsaicin attenuates hindbrain neuron responses to circulating cholecystokinin. , 1989, The American journal of physiology.
[421] G. Dockray,et al. Immunochemical Characterization of Peptides in Endocrine Cells and Nerves with Particular Reference to Gastrin and Cholecystokinin , 1981 .
[422] J. Morley,et al. Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome , 1986, Biological Psychiatry.
[423] S. Nicolaı̈dis,et al. Does cholecystokinin induce physiological satiety and sleep? , 1989, Brain Research.
[424] G. Zetler. Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam. , 1980, European journal of pharmacology.
[425] J. Rossier,et al. Inhibitory effect of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius , 1983, Brain Research.
[426] M. Beinfeld,et al. Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: Relationship to symptoms and drug response , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[427] Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[428] G. P. Smith,et al. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. , 1985, The American journal of physiology.
[429] R. Chang,et al. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. , 1989, European journal of pharmacology.
[430] T. Hökfelt,et al. Coexistence of substance P- and cholecystokinin-like immunoreactivity in neurons of the mesencephalic periaqueductal central gray , 1982, Neuroscience Letters.
[431] T. Gettys,et al. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. , 1990, The Journal of clinical endocrinology and metabolism.
[432] J. Haycock,et al. Ventral mesencephalic neurons containing both cholecystokinin‐ and tyrosine hydroxylase‐like immunoreactivities project to forebrain regions , 1989, The Journal of comparative neurology.
[433] F. Goodwin,et al. Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease , 1981, Brain Research.
[434] G. P. Smith,et al. C-terminal octapeptide of cholecystokinin decreases food intake in man. , 1981, The American journal of clinical nutrition.
[435] T. Nolan,et al. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.
[436] B. Costall,et al. Anxiolytic effects of CCK-B antagonists , 1991, Neuropeptides.
[437] R. J. Crosby,et al. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers , 1990, Brain Research.
[438] R. Lyman,et al. Feedback Regulation of Pancreatic Enzyme Secretion as a Mechanism for Trypsin Inhibitor-Induced Hypersecretion in Rats 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[439] L. F. Kolakowski,et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[440] P. Micevych,et al. Development of the limbic-hypothalamic cholecystokinin circuit: a model of sexual differentiation. , 1992, Developmental neuroscience.
[441] P. Kalivas,et al. Influence of cholecystokinin on central monoaminergic pathways , 1983, Regulatory Peptides.
[442] B. E. Evans,et al. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. , 1989, Journal of medicinal chemistry.
[443] H. Raybould. Capsaicin-sensitive vagal afferents and CCK in inhibition of gastric motor function induced by intestinal nutrients , 1991, Peptides.
[444] F. Weiss,et al. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats , 1988, Pharmacology Biochemistry and Behavior.
[445] M. R. Hokin. Studies on chemical mechanisms of the action of neurotransmitters and hormones. II. Increased incorporation of 32P into phosphatides as a second, adaptive response to pancreozymin or acetylcholine in pigeon pancreas slices. , 1968, Archives of biochemistry and biophysics.
[446] D. Hommer,et al. Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons. , 1983, European journal of pharmacology.
[447] K. Winckler,et al. Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. , 1978, Scandinavian journal of gastroenterology.
[448] E. Stricker,et al. Capsaicin pretreatment attenuates multiple responses to cholecystokinin in rats. , 1988, Journal of the autonomic nervous system.
[449] B. Bianchi,et al. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. , 1990, Journal of medicinal chemistry.
[450] James E. McGuigan,et al. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa , 1991, Regulatory Peptides.
[451] T. Berzin,et al. Diseases of the pancreas , 2022, Pathy's Principles and Practice of Geriatric Medicine.
[452] H. T. Debas,et al. Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. , 1978, The American journal of physiology.
[453] P. McHugh,et al. Cholecystokinin suppresses food intake by inhibiting gastric emptying. , 1982, The American journal of physiology.
[454] M. Palkovits,et al. Distribution of cholecystokinin (CCK) in the rat lower brain stem nuclei , 1982, Brain Research.
[455] T. Hökfelt,et al. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat , 1993, Neuroscience Letters.
[456] D. Hommer,et al. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide. , 1986, The Journal of pharmacology and experimental therapeutics.
[457] E. Corazziari,et al. Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog. , 1979, Gastroenterology.
[458] J. Morley,et al. Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. , 1983, The American journal of physiology.
[459] H. Weingarten,et al. Gastric emptying changes are neither necessary nor sufficient for CCK-induced satiety. , 1989, The American journal of physiology.
[460] M. Takita,et al. In vivo release of cholecystokinin-like immunoreactivity in rat frontal cortex under freely moving conditions , 1989, Neuroscience Letters.
[461] V. Go,et al. Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems , 1987, Brain Research.
[462] Manuel F. Gonzalez,et al. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718 , 1993, Neuroscience Letters.
[463] R. Gorski,et al. Cholecystokinin stimulates and inhibits lordosis behavior in female rats , 1987, Physiology & Behavior.
[464] C. Turkelson,et al. Role of cholecystokinin in intestinal phase and meal-induced pancreatic secretion. , 1989, The American journal of physiology.
[465] S. Ceccatelli,et al. A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin , 1988, Brain Research.
[466] J. Lauterborn,et al. Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain , 1987, Brain Research.
[467] M. Beinfeld. CCK mRNA expression, pro-CCK processing, and regulated secretion of immunoreactive CCK peptides by rat insulinoma (RIN 5F) and mouse pituitary tumor (AtT-20) cells in culture , 1992, Neuropeptides.
[468] S. Schiffmann,et al. Cholecystokinin distribution in the human striatum and related subcortical structures , 1989, Neurochemistry International.
[469] P. Ameglio,et al. Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys. , 1993, American Journal of Physiology.
[470] P. Frey. Cholecystokinin octapeptide (CCK 26–33), nonsulfated octapeptide and tetrapeptide (CCK 30–33) in rat brain: Analysis by high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA) , 1983, Neurochemistry International.
[471] J. Harro,et al. Cholecystokinin receptors and memory: A radial maze study , 1993, Pharmacology, Biochemistry and Behavior.
[472] G. P. Smith,et al. Cholecystokinin does not produce bait shyness in rats. , 1974, Physiology & behavior.
[473] Gerard P. Smith,et al. Hepatic-portal infusion reduces the satiating potency of CCK-8 , 1988, Physiology & Behavior.
[474] R. Jensen,et al. 8 – Cholecystokinin Receptor Antagonists: Ability to Distinguish Various Classes of Cholecystokinin Receptors , 1990 .
[475] L. Chiodo,et al. Release of cholecystokinin from rat midbrain slices and modulatory effect of D2 DA receptor stimulation , 1991, Brain Research.
[476] C. Beglinger,et al. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. , 1992, Gastroenterology.
[477] J. Polak,et al. IDENTIFICATION OF CHOLECYSTOKININ-SECRETING CELLS , 1975, The Lancet.